Hikma Pharmaceutical | HIK - Créanciers Commerciaux

Prix De L'Action
1,408.00
Variation Quotidienne
9.50 0.68%
Mensuellement
7.65%
Annuel
-29.81%
Q2 Prévisions
1,361.73




Créanciers Commerciaux Changement Date
Almirall EUR 258.05M 58.66M 2025-12
argenx SE USD 852.2M 369.5M 2025-06
AstraZeneca USD 22.51B 2.78B 2026-03
Autolus Therapeutics Ltd USD 3.08M 7.88M 2025-12
Bayer EUR 7.08B 700M 2025-12
Fresenius EUR 1.08B 65M 2025-09
Galapagos EUR 104.65M 4.02M 2025-12
Genmab DKK 6M 2M 2025-09
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Lonza CHF 471M 3M 2024-12
Merck EUR 2.11B 182M 2025-12
Orion EUR 150.3M 26.8M 2026-03
Recordati EUR 315.05M 15.17M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12